The Defensin Peptide Family: Alpha, Beta, and Theta Disulfide Classes
Defensins are ancient antimicrobial peptides of innate immunity, sorted into three structural classes — alpha, beta and theta. The dividing line is disulfide connectivity: which of six conserved cysteines bond to which. Here is how the alpha/beta/theta split works, where each class is made, and why researchers keep studying them.
by Research Assistant·
The defensin peptide family is one of the oldest weapons the immune system carries — small, positively charged peptides that pre-date antibody-based immunity by hundreds of millions of years. What makes the family so rewarding to study is how neatly nature files it. Every defensin is built on three disulfide bonds, and the exact pattern of those bonds sorts the whole family into three structural drawers labeled alpha, beta, and theta. The compounds discussed here are supplied strictly for research use only, and this article is an educational overview of their chemistry — not a guide to any human application. If you're reading a defensin paper, the class label is the single most useful fact you can bring to it: it tells you the peptide's shape, the tissue that makes it, and the kind of activity to expect.
What Are Defensins?
In plain terms, defensins are small, cysteine-rich, cationic peptides. "Cationic" just means they carry a net positive charge — which is exactly what draws them to the negatively charged surfaces of microbes. Most run between 18 and 45 amino acids long and carry three (occasionally four) conserved disulfide bonds. That's tiny by protein standards, roughly the size of a short signaling peptide. Yet the disulfide scaffolding makes them remarkably tough.
They turn up across the whole tree of life — vertebrates, invertebrates, plants, and fungi — which is a strong hint that they solve a very old problem. In vertebrates the family splits into three classes: alpha, beta, and theta. Alpha and beta are the two that humans express. Theta-defensins are the rare exception, found only in certain non-human primates. Their positive charge and compact fold place them alongside other cationic peptide classes that interact directly with membranes, though defensins earn their keep by disrupting microbes rather than slipping past healthy cells.
Here's the key idea to hold onto: the class boundaries are drawn by disulfide connectivity, not by sequence. Two defensins can share very little sequence and still land in the same class, simply because their cysteines bond in the same pattern.
The Shared Blueprint — Six Cysteines, Three Disulfide Bonds
This is the section that unlocks the rest. Every classical defensin is stitched together by three disulfide bonds between six cysteine residues. Think of a disulfide bond as a molecular staple: two sulfur atoms, one from each cysteine, lock together and pin distant parts of the chain into a fixed shape. Three staples in the right places produce a small, rigid fold that shrugs off heat and enzymes far better than an unstapled peptide of the same length.
In alpha- and beta-defensins those staples hold together a three-stranded antiparallel beta-sheet. The fold is amphipathic and polycationic — it keeps its water-loving positive charges on one face and its oily, membrane-loving residues on another. That split isn't cosmetic. It's precisely what lets a defensin sit down on a microbial membrane on one side while its charged side stays comfortable in water. To see how researchers actually confirm a fold like this at the bench, our explainer on how secondary structure is read by circular dichroism walks through the technique.
Cysteine connectivity is the classifier
The number of cysteines and disulfide bonds is the same across the family, so what actually separates alpha from beta from theta is which cysteine bonds to which. Label the six cysteines C1 through C6 in the order they appear along the chain, and the connectivity pattern becomes each class's fingerprint. That's the thread running through the three sections below.
Alpha-Defensins: C1–C6, C2–C4, C3–C5
The short version: alpha-defensins are the neutrophil-and-gut class, and their signature is the C1–C6, C2–C4, C3–C5 bonding pattern. In an alpha-defensin the first cysteine bonds to the sixth, the second to the fourth, and the third to the fifth. They're small even for defensins — roughly 2 to 6 kilodaltons, about 29 to 35 amino acids — folded into a compact globular shape with the cationic residues clustered at one pole.
Humans make six of them. Four, named HNP-1 through HNP-4 (HNP stands for human neutrophil peptide), are packed into neutrophils, the first-responder white blood cells. The other two, HD5 and HD6, come from Paneth cells deep in the crypts of the small intestine. All six are encoded by the genes DEFA1 through DEFA6, clustered together on chromosome 8p23. HNP-1 and HNP-3 differ by just a single amino acid at their tip — a neat illustration of how little sequence change separates close relatives.
The Paneth-cell alpha-defensins are especially interesting. Secreted into the intestinal crypt, they help shape which bacteria take up residence and shield the epithelial stem cells that renew the gut lining. In cell-culture and animal-model studies, a shortfall of these enteric defensins is associated with disturbed gut flora — one reason they keep surfacing in inflammatory-bowel research.
Beta-Defensins: C1–C5, C2–C4, C3–C6
Beta-defensins guard the body's surfaces, and they rewire the disulfide pattern to C1–C5, C2–C4, C3–C6. That single change in connectivity — the first cysteine now reaching to the fifth, the third to the sixth — is the entire structural difference between the alpha and beta classes, even though both fold into the same beta-sheet architecture.
They also do more than punch holes in microbes. Beta-defensins act as signaling molecules that call other immune cells to the scene: in research settings they promote the movement of monocytes, T-cells, and dendritic cells toward a site of infection. That chemotactic role effectively links the fast, general innate response to the slower, targeted adaptive one — a large part of why beta-defensins draw attention well beyond straightforward antimicrobial work.
How they're built is unusual too. A theta-defensin is assembled by joining two truncated, alpha-defensin-derived nine-residue pieces head to tail, then sealing the backbone into a loop — a macrocyclic octadecapeptide, in the technical phrasing. Closing the ring is what gives the class its standout property: strong resistance to the enzymes and heat that would chew up a normal linear peptide.
Then comes the twist that makes theta-defensins such a good research story. They're found in Old World monkeys such as the rhesus macaque — but not in humans, gorillas, bonobos, or chimpanzees. The strange part? Our genomes still carry the theta-defensin genes. They're transcribed into mRNA but never built into a peptide, because a premature stop codon halts production partway through. The genes sit in our DNA as pseudogenes, and whether their silencing gave early humans some advantage or was simply an accident of genetic drift is still an open question. When researchers reconstruct the peptide our ancestors would have made and synthesize it in the lab, they call it retrocyclin — and in cell-culture studies it shows activity against retroviruses including HIV, as well as herpes simplex virus and influenza A.
Once they gather, the peptides get to work on the membrane itself. In gram-negative bacteria they elbow aside the divalent cations — calcium and magnesium ions — that hold the outer lipopolysaccharide layer together, loosening that outer shell. The defensins then insert into the membrane and assemble into aqueous pores roughly 25 angstroms across. Those pores let the cell's contents leak out and let more peptide in, and the damage isn't something the microbe recovers from. Worth stressing: this entire picture comes from in-vitro and structural studies of the molecules themselves. It describes what the peptides do to microbial membranes in the lab, not any effect in a living body.
Why Researchers Study Defensins
The practical pull comes from a collision of two facts. Antibiotic resistance keeps climbing, and defensins hit a broad range of microbes through a physical, membrane-level mechanism that's hard for bacteria to sidestep. Put those together and the family looks like an appealing natural template for anyone designing new anti-infective molecules.
Two research threads show the interest at work. Retrocyclin, the reconstructed human theta-defensin, is studied as a scaffold for engineered antiviral peptides. And synthetic small molecules that mimic the charge-and-shape logic of defensins — brilacidin is the most cited example — have moved into clinical-trial evaluation as anti-infective and anti-inflammatory candidates. These are research and clinical-development stories, not endorsements of any product. As with any compound sharing a name with a drug candidate, research-grade material is not the same thing as an approved pharmaceutical. If this structural-family framing is useful, you might also read about another structurally defined peptide family organized around a shared molecular signature.
Frequently Asked Questions
What are the three classes of defensins?
Vertebrate defensins are grouped into alpha, beta, and theta classes. All three are small, cationic, cysteine-rich peptides built on three disulfide bonds, but they differ in how those bonds connect the six conserved cysteines — and, in the case of theta-defensins, in having a fully circular backbone. Alpha- and beta-defensins are the two classes expressed in humans; theta-defensins are found only in certain Old World monkeys.
How are alpha- and beta-defensins structurally different?
The defining difference is cysteine connectivity. In alpha-defensins the six cysteines pair C1–C6, C2–C4, and C3–C5, while in beta-defensins they pair C1–C5, C2–C4, and C3–C6. Both fold into a three-stranded antiparallel beta-sheet, but the different disulfide "wiring" gives each class a distinct shape and a different tissue distribution — alpha-defensins in neutrophils and Paneth cells, beta-defensins mainly across epithelial surfaces.
Why don't humans have theta-defensins?
Humans, gorillas, bonobos, and chimpanzees carry theta-defensin genes, but a premature stop codon in the coding sequence means the mRNA is transcribed and never translated into a functional peptide. The genes are therefore pseudogenes in these species. Whether their loss offered a selective advantage or was simply genetic drift is still an open research question.
What is retrocyclin?
Retrocyclin is a laboratory-synthesized peptide that reconstructs what a functional human theta-defensin would have looked like before the gene was silenced. In cell-culture and in-vitro studies it has shown activity against retroviruses including HIV, as well as herpes simplex virus and influenza A, which is why it is studied as a scaffold for engineered antiviral peptides.
The Bottom Line
The alpha/beta/theta split that organizes the defensin peptide family is, at heart, a disulfide-connectivity story. Six cysteines, three bonds, and three different ways of wiring them produce three classes — and that structural label maps cleanly onto where each class is made and what it does, from neutrophil-borne alpha-defensins to surface-guarding beta-defensins to the cyclic, human-silenced theta class. For researchers, the family is less a single molecule than an evolutionary blueprint, one that keeps informing the design of next-generation anti-infective peptides. To place defensins in their wider context, read our overview of antimicrobial peptides and how they act on membranes.
For research use only. Not for human or animal
consumption of any kind. The information in this article is for
educational purposes only and is not intended to diagnose, treat,
cure, or prevent any disease. The statements made have not been
evaluated by the U.S. Food and Drug Administration. These products
are NOT FDA APPROVED. Please consult with a licensed healthcare
professional before making any decisions regarding your health
or research.
Optides LLC is a chemical supplier. Optides LLC is not a
compounding pharmacy or chemical compounding facility as defined
under 503A of the Federal Food, Drug, and Cosmetic Act. Optides LLC
is not an outsourcing facility as defined under 503B of the Federal
Food, Drug, and Cosmetic Act.
